| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Parshall B Lynne is a Director at IONS, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 42 sales. Those positions are worth an estimated $4.7M at current prices.
Our model assigns Parshall B Lynne a strong insider score of 74/100, based on 20 past trades. Over a 12-month horizon, 93.3% of those trades were profitable, with an average 12-month return of +24.7%.
Parshall B Lynne's largest disclosed position is in IONS as Director, worth about $4.0M. The recent filings there lean toward selling, a net 246,805 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | CYTK Cytokinetics, Incorporated | Director | Sell | 5,000 | $71.48 | $357,400.00 | -31.7% | - | - | |
| Jun 1, 2026 | CYTK Cytokinetics, Incorporated | Director | Sell | 5,000 | $74.08 | $370,400.00 | -24.1% | - | - | |
| Apr 15, 2026 | IONS Ionis Pharmaceuticals, Inc. | Director | Sell | 5,000 | $76.27 | $381,366.52 | -8.9% | -28.5% | - | |
| Nov 19, 2025 | CYTK Cytokinetics Inc | Director | Sell | 5,000 | $64.73 | $323,650.00 | -17.9% | +2.8% | - | |
| Oct 15, 2025 | IONS Ionis Pharmaceuticals Inc | Director | Sell | 5,000 | $71.74 | $358,721.50 | -7.5% | +9.8% | - | |
| Sep 2, 2025 | IONS Ionis Pharmaceuticals Inc | Director | Sell | 20,000 | $50.91 | $1,018,297.50 | -23.2% | +42.6% | - | |
| Aug 6, 2025 | IONS Ionis Pharmaceuticals Inc | Director | Sell | 5,000 | $41.93 | $209,646.10 | -5.5% | +79.1% | - | |
| Sep 9, 2024 | CYTK Cytokinetics Inc | Director | Sale+OE | 5,000 | $54.92 | $274,600.00 | -19.5% | -9.5% | -7.8% | |
| Aug 26, 2024 | CYTK Cytokinetics Inc | Director | Sale+OE | 5,000 | $57.26 | $286,300.00 | -19.5% | -12.0% | -33.1% | |
| Aug 12, 2024 | CYTK Cytokinetics Inc | Director | Sale+OE | 5,000 | $55.20 | $276,000.00 | -19.5% | +4.3% | -38.9% |